According to authors of article, inclusion by korvitin à in the scheme of treatment of patient’s sharp heart attack of a myocardium improves a clinical current of disease, leads to reduction of the size of the centre of a heart attack of a myocardium, raises electric stability of heart, and has antioxidant action. Korvitin for injections, undoubtedly, is effective and perspective means cardio protection at patient’s sharp heart attack of a myocardium. It is safe in application and differs good shipping. Its inclusion in the standard scheme of treatment of patient’s sharp heart attack of a myocardium, both at carrying out revascularation and without it, will allow to provide more favorable current of the hospital period and to improve the remote forecast.
Parkhomenko, A.N. and Kojukhov, S.N.
"NEW POSSIBILITIES IN TREATMENT OF PATIENTS AT A SHARP HEART ATTACK OF A MYOCARDIUM,"
Central Asian Journal of Pediatrics: Vol. 2
, Article 11.
Available at: https://uzjournals.edu.uz/pediatrics/vol2/iss2/11